AUGUSTA, Maine (AP) — The federal government has expanded its list of health organizations that received products from a Massachusetts pharmacy implicated in a fungal meningitis outbreak, and the updated list includes more than 30 facilities in Maine.
The Food and Drug Administration list includes medical practices in each state that received products since May from the New England Compounding Center, the Framingham, Mass., pharmacy at the center of the multistate outbreak.
No one in Maine has been affected by the fungal meningitis outbreak. While health facilities in the state have purchased products from the New England Compounding Center, state health officials say the injectable steroid blamed in the meningitis outbreak was not used in Maine.
The outbreak has caused more than 300 illnesses and 23 deaths nationally.
Expanded FDA list: http://www.fda.gov/downloads/Drugs/DrugSafety/FungalMeningitis/UCM325467.pdf